Back to top

Kairos Pharma, Bayer partner on prostate cancer therapy

Kairos Pharma, Ltd. ( ($KAPA) ) just unveiled an update. On July 16, 2026, Kairos Pharma entered into an investigator-initiated research agreement ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: